Advertisement
Mylan

Mylan Issues Voluntary Recall of Some EpiPen Auto-Injectors

0
Rare cases of 'failure to activate' spurred the action, company says
Insurance products offered by hospitals and health systems

Vertical Integration Insurance Products of Higher Quality

0
Slight increase in percentage of insurance products offered by hospitals, health systems from 2011-2015
Nine out of 10 American doctors are happy with their choice of profession

90 Percent of U.S. Physicians Satisfied With Career Choice

0
AMA survey of physicians, residents, and medical students finds most are satisfied despite challenges
Dupixent (dupilumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe eczema that isn't well controlled by topical medication.

FDA Approves Dupixent to Treat Eczema

0
Active ingredient binds to protein (interleukin-4 receptor alpha subunit) that causes inflammation
In a position paper published online March 28 in the Annals of Internal Medicine

ACP Issues Challenge to Cut Task Burden and Put Patients First

0
American College of Physicians details policy recommendations to reduce administrative burden
The volume of insurance advertisements during the first Affordable Care Act enrollment period correlated with change in uninsurance rates

TV Ads for ACA Enrollment Linked to Decline in Uninsured Rates

0
Counties exposed to higher volumes of local insurance ads had larger drop in uninsurance
From 1992 to 2014 there was a decrease in the rate of malpractice claims paid on behalf of physicians in the United States

Paid Malpractice Claims Cut in Half From 1992 to 2014 in U.S.

0
But, increase in mean compensation amounts and percentage of paid claims exceeding $1 million
Prophylactic use of the subcutaneous C1 inhibitor CSL830 is associated with a reduction in the frequency of acute attacks in patients with hereditary angioedema

C1 Inhibitor Use Reduces Attacks in Hereditary Angioedema

0
Subcutaneous CSL830 at doses of 40 and 60 IU reduce rate of attacks, need for rescue medication
Patients admitted to the hospital during The Joint Commission on-site inspections (surveys) have reduced mortality compared to that seen during non-survey weeks

30-Day Mortality Down During Joint Commission Survey Weeks

0
Patients admitted during survey weeks (versus non-survey weeks) have significantly lower mortality
Children aged 4 to 9 years with atopic dermatitis and with frequent use of emollients have increased urinary levels of low-molecular weight phthalate metabolites and parabens

Phthalate, Paraben Levels Up in Children With Atopic Dermatitis

0
Increased urinary levels for children aged 4 to 9 years with AD and for frequent use of emollients